China’s ADR monitoring system also has limitations at this moment, the number of ADR reporting and types of drugs is growing continually, large amounts of data in the database, resulting in not only the work efficiency of ADR reporting of each province is inefficient, statistical analysis is difficult, the results are not precise, but also
(Read More…)




